Evidence map›Paper›PMID 41909612›Full record

ReviewBiophysical reviews2026

Through the holes: the biotechnological potential of actinoporins (and other PFPs).

Javier Maraver-de-Paz, Diego Heras-Márquez, Juan Palacios-Ortega, Álvaro Martínez-Del-Pozo, Sara García-Linares

Abstract readReview
In one paragraph

Review in Biophysical reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Javier Maraver-de-PazDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, 28020 Spain.
Diego Heras-MárquezDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Juan Palacios-OrtegaDepartment of Chemistry, Faculty of Natural, Mathematical and Engineering Sciences, King's College London, 7 Trinity Street, SE1 1DB London, UK.
Álvaro Martínez-Del-PozoDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, 28020 Spain.
Sara García-LinaresDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, 28020 Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pore-forming proteins (PFPs) are singular polypeptides used by all kinds of organisms for attack or defence. They defy the stereotypical classification between water-soluble and membrane proteins. Within this large family of proteins, bacterial hemolysins and sea anemone actinoporins stand out as candidates for transforming these toxins into therapeutic or biotechnological devices. Over the past two decades, many examples have been published where these toxic proteins have been adapted to perform single-molecule tasks such as biosensing, sequencing of proteins and nucleic acids, discriminating protein chemical modifications, proteomics analyses, or even the use of DNA in computational approaches. Lately, PFPs have also been incorporated as templates for designing new artificial nanoreactors to catalyse different chemical reactions. A promising alternative within this idea is the recent publication of a proof of concept showing that actinoporins can be converted into biosustainable plastic-degrading nanoreactors. It is also discussed how optimisation and development of future PFP-based nanoreactors with improved activity and new specificities seem to be a venue worth to explore in order to degrade the contaminating waste material made of plastics from very different chemical compositions.

Indexed as

BiosensorsMicroplastic recyclingNanoporesNanoreactorsPET degradationPore-forming proteinsProtein engineeringSphingomyelin

Identifiers

PMID41909612
PMCPMC13031482

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.